Bridging regenerative medicine based therapies into the 21st Century: solo or symphony?

  • Mariangela Peruzzi Sapienza University of Rome
  • Giuseppe Biondi Zoccai Sapienza University of Rome
  • Luigi Frati Sapienza University of Rome
  • Elena De Falco Sapienza University of Rome
  • Isotta Chimenti Sapienza University of Rome
  • Ernesto Greco Sapienza University of Rome
  • Antonino GM Marullo Sapienza University of Rome
  • Giacomo Frati Sapienza University of Rome
  • Piergiusto Vitulli

Abstract

Clinical translation in the field of regenerative medicine means manufacturing a safe, reproducible and effective clinical product for the benefit of patients. This represents the ultimate goal of applied research, but beyond researchers and clinicians, multiple intermediate players are involved, including other researchers, reviewers, funding agencies, scientific societies, guideline authors, and policy regulators. Consequently, bridging translational research and regenerative medicine therapies into the 21st Century requires a resolute effort. We envisage that strategic and synergistic efforts in seven key areas will facilitate the mainstream adoption and implementation of regenerative medicine based therapies.

Published
May 25, 2015
How to Cite
PERUZZI, Mariangela et al. Bridging regenerative medicine based therapies into the 21st Century: solo or symphony?. International Archives of Medicine, [S.l.], v. 8, may 2015. ISSN 1755-7682. Available at: <http://imed.pub/ojs/index.php/iam/article/view/960>. Date accessed: 03 dec. 2020. doi: http://dx.doi.org/10.3823/1680.
Section
Translational Cardiology

Keywords

basic research; cardiovascular disease; outcome research; translational research